Lung Cancer Staging in the Genomics Era

Thoracic Surgery Clinics

Volumn 16, Issue 4, 2006, Pages 329-337

  Nguyen, Dao M ^a   Schrump, David S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; OLIGONUCLEOTIDE; PROTEIN; TRANSCRIPTOME; TUMOR MARKER;

CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; DNA MICROARRAY; GENE; GENE EXPRESSION PROFILING; GENOMICS; HEALTH CARE ORGANIZATION; HISTOPATHOLOGY; HUMAN; HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MICROARRAY ANALYSIS; MOLECULAR TYPING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; RISK; SCANNING ELECTRON MICROSCOPY; STANDARDIZATION; STRATIFICATION; TRANSCRIPTOMICS; TREATMENT RESPONSE; VALIDATION STUDY;

DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MICROARRAY ANALYSIS; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 33751537106     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2006.07.004     Document Type: Review

References (43)

1. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 111 6 (1997) 1710-1717
2. Mountain C.F. Staging classification of lung cancer. A critical evaluation. Clin Chest Med 23 1 (2002) 103-121
3. D'Amico T.A. Molecular biologic staging of non-small cell lung cancer. J Thorac Cardiovasc Surg 123 (2002) 409-410
4. Winton T., Livingston R., Johnson D., et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352 25 (2005) 2589-2597
5. Arriagada R., Bergman B., Dunant A., et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350 4 (2004) 351-360
6. Kato H., Ichinose Y., Ohta M., et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 350 17 (2004) 1713-1721
7. Hotta K., Matsuo K., Kiura K., et al. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer. Curr Opin Oncol 18 2 (2006) 144-150
8. D'Amico T.A. Molecular staging and the selection of therapy for non-small cell lung cancer. Semin Thorac Cardiovasc Surg 17 3 (2005) 180-185
9. D'Amico T.A., Aloia T.A., Moore M.B., et al. Predicting the sites of metastases from lung cancer using molecular biologic markers. Ann Thorac Surg 72 4 (2001) 1144-1148
10. D'Amico T.A., Aloia T.A., Moore M.B., et al. Molecular biologic substaging of stage I lung cancer according to gender and histology. Ann Thorac Surg 69 3 (2000) 882-886
11. D'Amico T.A., Massey M., Herndon J., et al. A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. J Thorac Cardiovasc Surg 117 4 (1999) 736-743
12. Brundage M.D., Davies D., and Mackillop W.J. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 122 3 (2002) 1037-1057
13. Schena M., Shalon D., Heller R., et al. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 93 20 (1996) 10614-10619
14. Velculescu V.E., Zhang L., Zhou W., et al. Characterization of the yeast transcriptome. Cell 88 2 (1997) 243-251
15. Zhang L., Zhou W., Velculescu V.E., et al. Gene expression profiles in normal and cancer cells. Science 276 5316 (1997) 1268-1272
16. Yanagisawa K., Xu B.J., Carbone D.P., et al. Molecular fingerprinting in human lung cancer. Clin Lung Cancer 5 2 (2003) 113-118
17. Garber M.E., Troyanskaya O.G., Schluens K., et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 98 24 (2001) 13784-13789
18. Bremnes R.M., Camps C., and Sirera R. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 51 2 (2006) 143-158
19. Anbazhagan R., Tihan T., Bornman D.M., et al. Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. Cancer Res 59 20 (1999) 5119-5122
20. Bhattacharjee A., Richards W.G., Staunton J., et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 98 24 (2001) 13790-13795
21. Wigle D.A., Jurisica I., Radulovich N., et al. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res 62 11 (2002) 3005-3008
22. Blackhall F.H., Wigle D.A., Jurisica I., et al. Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study. Lung Cancer 46 2 (2004) 197-204
23. Gordon G.J., Jensen R.V., Hsiao L.L., et al. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res 62 17 (2002) 4963-4967
24. Beer D.G., Kardia S.L., Huang C.C., et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8 8 (2002) 816-824
25. Miura K., Bowman E.D., Simon R., et al. Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. Cancer Res 62 11 (2002) 3244-3250
26. Gordon G.J., Richards W.G., Sugarbaker D.J., et al. A prognostic test for adenocarcinoma of the lung from gene expression profiling data. Cancer Epidemiol Biomarkers Prev 12 9 (2003) 905-910
27. Inamura K., Fujiwara T., Hoshida Y., et al. Two subclasses of lung squamous cell carcinoma with different gene expression profiles and prognosis identified by hierarchical clustering and non-negative matrix factorization. Oncogene 24 47 (2005) 7105-7113
28. Virtanen C., Ishikawa Y., Honjoh D., et al. Integrated classification of lung tumors and cell lines by expression profiling. Proc Natl Acad Sci USA 99 19 (2002) 12357-12362
29. Wang T., Hopkins D., Schmidt C., et al. Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis. Oncogene 19 12 (2000) 1519-1528
30. Bild A.H., Yao G., Chang J.T., et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439 7074 (2006) 353-357
31. Petersen S., Heckert C., Rudolf J., et al. Gene expression profiling of advanced lung cancer. Int J Cancer 86 4 (2000) 512-517
32. Kikuchi T., Daigo Y., Katagiri T., et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 22 14 (2003) 2192-2205
33. Hoang C.D., D'Cunha J., Tawfic S.H., et al. Expression profiling of non-small cell lung carcinoma identifies metastatic genotypes based on lymph node tumor burden. J Thorac Cardiovasc Surg 127 5 (2004) 1332-1341
34. Borczuk A.C., Shah L., Pearson G.D., et al. Molecular signatures in biopsy specimens of lung cancer. Am J Respir Crit Care Med 170 2 (2004) 167-174
35. Kallioniemi A., Kallioniemi O.P., Sudar D., et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258 5083 (1992) 818-821
36. Shibata T., Uryu S., Kokubu A., et al. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features. Clin Cancer Res 11 17 (2005) 6177-6185
37. Kim T.M., Yim S.H., Lee J.S., et al. Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers. Clin Cancer Res 11 23 (2005) 8235-8242
38. Balsara B.R., and Testa J.R. Chromosomal imbalances in human lung cancer. Oncogene 21 45 (2002) 6877-6883
39. Velculescu V.E., Zhang L., Vogelstein B., et al. Serial analysis of gene expression. Science 270 5235 (1995) 484-487
40. Nacht M., Dracheva T., Gao Y., et al. Molecular characteristics of non-small cell lung cancer. Proc Natl Acad Sci USA 98 26 (2001) 15203-15208
41. Dobbin K.K., Beer D.G., Meyerson M., et al. Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin Cancer Res 11 (2005) 565-572
42. Parmigiani G., Garrett-Mayer E.S., Anbazhagan R., et al. A cross-study comparison of gene expression studies for the molecular classification of lung cancer. Clin Cancer Res 10 9 (2004) 2922-2927
43. National Cancer Institute. Available at: http://www.cancerdiagnosis.nci.nih.gov/challenge/index.html#organ. Accessed: April, 2006.